Medpace Holdings (MEDP) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Medpace (MEDP) PT Raised to $35.50 at Jefferies; Reiterates Hold
February 28, 2017 9:26 AM ESTJefferies raised its price target on Medpace (NASDAQ: MEDP) to $35.50 (from $34.00) while maintaining a Hold rating. Guidance targets revenue growth of ~7.5% (~8% CC), below consensus' 11.4%. Yet, guidance does bracket Net Income and EPS estimates.
Analyst David Windley commented, "Medpace boasts eye-popping margin,... More
